نتائج البحث - Michele Figus

  • يعرض 1 - 15 نتائج من 15
تنقيح النتائج
  1. 1
    Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options

    Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options حسب Francesco Sartini, Michele Figus, Marco Nardi, Giamberto Casini, Chiara Posarelli

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Innovations in Glaucoma Surgery: Improving the Results

    Innovations in Glaucoma Surgery: Improving the Results حسب Michele Figus, Shlomo Melamed, Antonio Ferreras, Giorgio Marchini, Vital Paulino Costa

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Clinical pharmacology of intravitreal anti-VEGF drugs

    Clinical pharmacology of intravitreal anti-VEGF drugs حسب Stefano Fogli, Marzia Del Re, Eleonora Rofi, Chiara Posarelli, Michele Figus, Romano Danesi

    منشور في 2018
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Cannabinoids in Glaucoma Patients: The Never-Ending Story

    Cannabinoids in Glaucoma Patients: The Never-Ending Story حسب Andrea Passani, Chiara Posarelli, Angela Tindara Sframeli, Laura Perciballi, Marco Pellegrini, Gianluca Guidi, Michele Figus

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Cross-Linked Hyaluronic Acid as Tear Film Substitute

    Cross-Linked Hyaluronic Acid as Tear Film Substitute حسب Chiara Posarelli, Andrea Passani, Marzia Del Re, Stefano Fogli, Mario Damiano Toro, Antonio Ferreras, Michele Figus

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study

    Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study حسب Raj Bhayani, J.M. Martínez-de-la-Casa, Michele Figus, Karsten Klabe, Alessandro Rabiolo, Karl Mercieca

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma

    European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma حسب Antonio Maria Fea, Alain M. Bron, Mario A. Economou, Gianluca Laffi, Enrico Martini, Michele Figus, Francesco Oddone

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Sirolimus as a second-line treatment for Graves’ orbitopathy

    Sirolimus as a second-line treatment for Graves’ orbitopathy حسب Giulia Lanzolla, Maria Novella Maglionico, Simone Comi, Francesca Menconi, Paolo Piaggi, Chiara Posarelli, Michele Figus, Claudio Marcocci, Michele Marinò

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema

    Validation of an Automated Artificial Intelligence Algorithm for the Quantification of Major OCT Parameters in Diabetic Macular Edema حسب Edoardo Midena, Lisa Toto, Luisa Frizziero, Giuseppe Covello, Tommaso Torresin, Giulia Midena, Luca Danieli, Elisabetta Pilotto, Michele Figus, Cesare Mariotti, Marco Lupidi

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity

    Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity حسب Luca Agnifili, Maria Ludovica Ruggeri, Michele Figus, Luca Virgilio Corboli, Michele Fornaro, Giuseppe Covello, Rodolfo Mastropasqua, Marta Di Nicola, A Marotta, Leonardo Mastropasqua

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Five-year follow-up of secondary iris-claw intraocular lens implantation for the treatment of aphakia: Anterior chamber versus retropupillary implantation

    Five-year follow-up of secondary iris-claw intraocular lens implantation for the treatment of aphakia: Anterior chamber versus retropupillary implantation حسب Mario Damiano Toro, Antonio Longo, Teresio Avitabile, Katarzyna Nowomiejska, Caterina Gagliano, Sarah Tripodi, Tomasz Chorągiewicz, Agnieszka Kamińska, Michele Figus, Chiara Posarelli, Matteo Forlini, Anselm G. Jünemann, Michele Reibaldi, Robert Ręjdak

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics

    Blindness and Glaucoma: A Multicenter Data Review from 7 Academic Eye Clinics حسب Luca Rossetti, Maurizio Digiuni, Giovanni Montesano, Marco Centofanti, Antonio Maria Fea, Michele Iester, Paolo Frezzotti, Michele Figus, Antonio Ferreras, Francesco Oddone, Lucia Tanga, Teresa Rolle, Valentina Battaglino, Chiara Posarelli, I. Motolese, Pietro Mittica, Simone Alex Bagaglia, Cristina Menicacci, Stefano De Cillà, Alessandro Autelitano, Paolo Fogagnolo

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers

    Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers حسب Roberto dell’Omo, Mariaelena Filippelli, Gianni Virgili, Francesco Bandello, Giuseppe Querques, Paolo Lanzetta, Teresio Avitabile, Francesco Viola, Michele Reibaldi, Francesco Semeraro, Luciano Quaranta, Stanislao Rizzo, Edoardo Midena, Giuseppe Campagna, Ciro Costagliola, Paola Marolo, Carlo Enrico Traverso, Michele Iester, Carlo Alberto Cutolo, Claudio Azzolini, Simone Donati, Elias Premi, Paolo Nucci, Stela Vujosevic, Giovanni Staurenghi, Ferdinando Bottoni, F. Romano, Domenico Grosso, Enrico Borrelli, Riccardo Sacconi, Paolo Milella, Simone Ganci, Mario R. Romano, Gabriella Ricciardelli, Davide Allegrini, Marco Casaluci, Davide Romano, Giorgio Marchini, Francesca Chemello, Camilla Amantea, Rino Frisina, Elisabetta Pilotto, Raffaele Parrozzani, Daniele Veritti, Valentina Sarao, Daniele Tognetto, Massimo Busin, Francesco Parmeggiani, Katia De Nadai, Luca Furiosi, Rodolfo Mastropasqua, Bruno Battaglia, Matteo Gironi, Stefano Gandolfi, Enrico Luciani, Paolo Mora, Costantino Schiavi, Patrizia Bertaccini, Alessandro Finzi, Matilde Roda, Carlo Cagini, Marco Lupidi, Fabrizio Giansanti, Daniela Bacherini, Gianmarco Tosi, E. Benedetto, Marco De Nardi, Michele Figus, Chiara Posarelli, Cesare Mariotti, Vittorio Pirani, Michele Nicolai, Stefano Bonini, Marco Coassin, Antonio Di Zazzo, Maria Cristina Savastano, Alfonso Savastano, Gloria Gambini, Umberto De Vico, Leopoldo Spadea, Andrea Iannaccone, Carlo Nucci, Federico Ricci, Francesco Aiello, Gabriele Gallo Afflitto, Leonardo Mastropasqua, Giada D’Onofio, Federica Evangelista, Lorenza Brescia, Pasquale Napolitano, Paolo Polisena, Nicolina Gianfrancesco, Domenico Trivisonno, Francesco Petti, Francesca Simonelli, Settimio Rossi, Antonio Tartaglione, Nicola Rosa, Maddalena De Bernardo, Cristiana Iaculli

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)

    Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2) حسب Jason Bacharach, Andrew J. Tatham, Gloria E. Ferguson, Sandra Belalcázar, Hagen Thieme, Margot L. Goodkin, Michelle Y. Chen, Qiang Guo, Jeen Liu, Michael R. Robinson, Marina Bejanian, David Wirta, Arturo Alezzandrini, Gabriel Bercovich, Pablo Deromedis, Federico Furno Sola, Carolina Gentile, S. Lerner, Anahi Lupinacci, Carlos Zeolite, Catherine M. Birt, Andrew Crichton, Sébastien Gagné, Michael Giunta, Paul Harasymowycz, Delan Jinapriya, Marcelo T. Nicolela, Donald R. Nixon, Patrick Saurel, David Yan, Darana Yuen, Santiago Arango, Sandra Belalcázar, Alexander Martínez, Juan Camilo Restrepo, Vladimír Korda, Jana Kadlecová, Jitka Svačinová, Hany A. Khairy, Hani El Ibiary, Zeinab El Sanabary, Katharina Bell, Roman Greslechner, Joerg Michael Koch, K Lorenz, Isabel Oberacher-Velten, Stefanie Schmickler, C Schuart, Hagen Thieme, Francesco Bandello, Carlo Cagini, Michele Figus, Leonardo Mastropasqua, Luca Rossetti, Maurizio G. Uva, Sandragasu Thayanithi, Anthony P. Wells, Rahat Husain, Victor Koh, Dawn Lim, Tin Aung, Petrus Gous, Lynette Venter, Changwon Kee, Michael S. Kook, Ki Ho Park, Muhsin Eraslan, Özcan Kayıkçıoğlu, Nilgün Yıldırım, Rupert Bourne, Anshoo Choudhary, M. Francesca Cordeiro, Vincent Dubois, James Kirwan, Sheng Yang Lim, Keith R. Martin, Antony Nithy, Avinash Prabhu, Andrew J. Tatham, Ahmad Amir, Jason Bacharach, Howard Barnebey, Allen D. Beck, Lance Bergstrom, Navaneet S.C. Borisuth, James D. Branch, Jonathan Briggs, Stephen Bylsma, Peter Chang, William C. Christie, Frank Cotter, Michael Depenbusch, Damien F. Goldberg, Jack V. Greiner, Shailesh Gupta, Ron Gutmark, Ying Han, Sebastian Heersink, Malik Y. Kahook, Albert S Khouri

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

    Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial حسب Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi, Ramin Tadayoni, Carl J. Danzig, David Eichenbaum, Jason Hsu, Charles C. Wykoff, Jeffrey S. Heier, David R. Lally, Jordi Monés, Jared S. Nielsen, Veeral Sheth, Peter K. Kaiser, Julie Clark, Liansheng Zhu, Hersh Patel, Justin Tang, Dhaval Desai, Glenn J. Jaffe, Arturo Alezzandrini, A Francone, Joaquín Bafalluy, Silvina Bainttein, José D. Luna, Mario Saravia, Matko Vidosevich, Carlos Zeolite, Federico Furno Sola, Andrew Chang, Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella, Michele Figus

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: